Key result
Use of lipid-lowering drugs in Ireland increased fourfold from 1994 to 1998 but reached only 2.3% of the 5.8% target population of middle-aged men, often at sub-therapeutic 10-mg doses.
Observational
Yes
Despite rapid growth in statin use following landmark trials, prescribing in the community often failed to target the highest-risk populations or utilize evidence-based dosages.
No takes yet. Share an insight, caveat, or question.
Prescribing of lipid-lowering drugs rose fourfold post-trials; leaves open whether uptake reached middle-aged men with established benefit.
J. Feely (2000) conducted an observational in Coronary heart disease. Lipid-lowering drugs (statins) was evaluated on Prescribing rates of lipid-lowering drugs. Use of lipid-lowering drugs in Ireland increased fourfold from 1994 to 1998 but reached only 2.3% of the 5.8% target population of middle-aged men, often at sub-therapeutic 10-mg doses.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: